UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): September 16, 2003
ENDOCARE, INC.
(Exact name of registrant as specified in its charter)
DELAWARE
(State or other jurisdiction of incorporation)
0-27212 33-0618093
(Commission File Number) (IRS Employer Identification No.)
201 TECHNOLOGY DRIVE, IRVINE, CALIFORNIA 92618
(Address of principal executive offices, including zip code)
(949) 450-5400
(Registrant's telephone number, including area code)
ITEM 5. OTHER EVENTS
Based on information provided to KPMG LLP, the former principal
accountants for the Company, KPMG LLP sent a letter to the Company's audit
committee dated September 16, 2003 advising the audit committee that KPMG LLP's
report dated February 19, 2002, except as to notes 1 and 15, which are as of
March 25, 2002, on the Company's consolidated financial statements as of
December 31, 2000, and for the years ended December 31, 2000 and 1999, can no
longer be relied upon. A copy of KPMG LLP's September 16, 2003 letter to the
Company's audit committee is attached hereto as Exhibit 99.1
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS.
(c) Exhibits.
99.1 Letter from KPMG LLP to the Audit Committee of the Board of
Directors of Endocare, Inc., dated September 16, 2003.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report on Form 8-K to be signed on its
behalf by the undersigned hereunto duly authorized.
ENDOCARE, INC.
By: /s/ Katherine Greenberg
Date: September 18, 2003 ------------------------------------
Katherine Greenberg
Chief Financial Officer
EXHIBIT INDEX
EXHIBIT NO. DESCRIPTION
----------- -----------
99.1 Letter from KPMG LLP to the Audit Committee of the Board of
Directors of Endocare, Inc., dated September 16, 2003.